Heart Hospital of New Mexico at Lovelace Medical Center

Heart Hospital of New Mexico at Lovelace Medical Center achieves first implantation of Ovation Alto™ Abdominal Stent Graft System

Press Release

ALBUQUERQUE – April 3, 2017 – Steven Henao, M.D., chief vascular surgeon of New Mexico Heart Institute performed the first implant of the Ovation Alto™ Abdominal Stent Graft system in a patient on Thursday, March 30 at Heart Hospital of New Mexico at Lovelace Medical Center.

The Ovation Alto is manufactured by Endologix Corporation and is designed to treat abdominal aortic aneurysm (AAA).

Heart Hospital of New Mexico at Lovelace Medical Center implants new WATCHMAN Left Atrial Appendage Closure

Press Release
ALBUQUERQUE – March 8, 2017 – Physicians at Heart Hospital of New Mexico at Lovelace Medical Center recently implanted the WATCHMAN™ Left Atrial Appendage Closure (LAAC) device in a New Mexico patient.
 
The device offers patients with non-valvular atrial fibrillation (AF) an alternative to long-term Warfarin blood-thinning medication.
 
People with atrial fibrillation have a five times greater risk of stroke. Atrial fibrillation can cause blood to pool and form clots in the left atrial appendage (LAA).

Heart Hospital of New Mexico at Lovelace Medical Center implants first-of-its-kind naturally dissolving heart stent in patient with coronary artery disease

Press Release
ALBUQUERQUE, OCTOBER 4, 2016 — Heart Hospital of New Mexico at Lovelace Medical Center today became the first hospital in the state to offer patients with coronary artery disease a new treatment option that literally disappears over time. 
 
The Abbott Absorb bioresorbable vascular scaffold is the world’s first FDA-approved dissolving heart stent. Physicians at Heart Hospital of New Mexico at Lovelace Medical Center today began using the new stent on patients with coronary artery disease, which affects 15 million people in the U.S.